Litcius/Paper detail

Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease

Avner Thaler, Nurit Omer, Nir Giladi, Tanya Gurevich, Anat Bar‐Shira, Mali Gana‐Weisz, Orly Goldstein, Meir Kestenbaum, Jesse M. Cedarbaum, Avi Orr‐Urtreger, Shani Shenhar‐Tsarfaty, Anat Mirelman

2021Journal of Neurology17 citationsDOI

Topics & Concepts

LRRK2Internal medicineMedicineParkinson's diseaseCreatinineGastroenterologyRenal functionDiseaseNeurologyNeutrophil to lymphocyte ratioLymphocytePsychiatryParkinson's Disease Mechanisms and TreatmentsLysosomal Storage Disorders ResearchNeurological diseases and metabolism
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson’s disease | Litcius